SCML2 Activators
The chemical class termed SCML2 Activators includes a range of compounds that indirectly influence the activity of SCML2 through their impact on chromatin organization and gene regulation. These activators primarily function by altering the epigenetic landscape, thereby creating conditions that can modulate SCML2's role in chromatin dynamics and transcriptional control.
Compounds such as 5-Azacytidine, a DNA methyltransferase inhibitor, and various histone deacetylase (HDAC) inhibitors like Trichostatin A, Sodium Butyrate, Vorinostat, Valproic Acid, and SAHA (Vorinostat), modify the epigenetic marks on DNA and histones. These changes in the epigenetic landscape can influence the accessibility of chromatin, thereby potentially affecting the activity of SCML2 in regulating gene expression. The altered chromatin state can enhance or diminish the ability of SCML2 to interact with chromatin, thereby modulating its role in gene regulation. Additionally, compounds like Nicotinamide, which inhibits sirtuin HDACs, and other specific HDAC inhibitors like Mocetinostat, Romidepsin, Panobinostat, Entinostat, and Belinostat, further contribute to the modification of chromatin structure. These compounds, through their epigenetic modulation, can influence the way SCML2 interacts with chromatin and its associated proteins, affecting its role in gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which can alter chromatin structure and potentially influence SCML2 activity in gene regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Another histone deacetylase inhibitor, it can modify chromatin structure, potentially affecting SCML2 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that can alter chromatin dynamics, potentially influencing SCML2's function in gene regulation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Acts as an HDAC inhibitor, affecting chromatin remodeling, which could influence SCML2 activity. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
An inhibitor of sirtuin HDACs, potentially influencing chromatin organization and SCML2's activity. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
An HDAC inhibitor, potentially affecting chromatin structure and SCML2-mediated gene regulation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
An HDAC inhibitor, it can modify chromatin architecture, potentially influencing SCML2 activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A broad-spectrum HDAC inhibitor, potentially affecting chromatin remodeling and SCML2 function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
An HDAC inhibitor, it may impact chromatin structure and SCML2's role in gene regulation. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
An HDAC inhibitor that can modify the chromatin landscape, potentially influencing SCML2 activity. | ||||||